|
|
 |
|
Viewing report
|
|
|
|
The CRO Market Outlook to 2016
Business Insights, Nov 2011, Pages: 154
This report examines CRO markets in the US, Eastern Europe, Western Europe, China, India, Other Asia, and Latin America. Leading players are profiled and compared according to capability. The report also maps out the the future of the industry through to 2016.
Features and benefits:
- Forecast the market size for contract research in the US, Eastern Europe, Western Europe, China, India, Other Asia, and Latin America.
- Discover the opportunities presented by emerging CRO markets and optimize your research sourcing strategies.
- Understand how CRO utilization is evolving, and what the future of the industry is.
- Assess the growth potential of the industry and understand how leading players are taking advantage of the opportunities in this market.
- Compare and contrast capabilities of leading CROs in each region and identify potential partners or rivals.
Highlights:
- New economic challenges coming to light in 2011 will further pressure the industry, making drug maker financial performance even more important and tightening access to capital for smaller players.
- A variety of factors are fueling strong and continued increases in CRO usage including vertical integration, risk sharing programs, overall growth of R&D spending, biotech expansion, adaptive trials, and technology such as ePRO.
- In 2012 and 2013, economic and industry pressures will have the net effect of reducing overall drug development activity, particularly R&D conducted in-house. Although contract services will also be affected, they will continue to be considered more attractive, with a higher cost-benefit ratio than in-house drug development.
Your key questions answered:
- What factors are underpinning the growth of the CRO market?
- Why is M&A activity of CROs high and why will this continue?
- How is demand for different types of CRO services changing?
- Which are the leading CROs in each region and why?
- What regions will experience the greatest growth of CRO activity and how can drug developers optimize their work with CROs in these areas?
Product samples
A sample for this product is available. Please Login/Register to download this sample.
|
|
|
|
